BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 23185615)

  • 1. Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.
    Riddell JR; Maier P; Sass SN; Moser MT; Foster BA; Gollnick SO
    PLoS One; 2012; 7(11):e50394. PubMed ID: 23185615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
    Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
    Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter.
    Ramanathan M; Pinhal-Enfield G; Hao I; Leibovich SJ
    Mol Biol Cell; 2007 Jan; 18(1):14-23. PubMed ID: 17065555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculature.
    Riddell JR; Bshara W; Moser MT; Spernyak JA; Foster BA; Gollnick SO
    Cancer Res; 2011 Mar; 71(5):1637-46. PubMed ID: 21343392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-angiogenic effects of MDM2 through HIF-1α and NF-κB mediated mechanisms in LNCaP prostate cancer cells.
    Muthumani P; Alagarsamy K; Dhandayuthapani S; Venkatesan T; Rathinavelu A
    Mol Biol Rep; 2014 Aug; 41(8):5533-41. PubMed ID: 24972565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of hypoxia-induced angiogenesis by LDL involves a HIF-centered signaling network linking inflammatory TNFα and angiogenic VEGF.
    Jin F; Zheng X; Yang Y; Yao G; Ye L; Doeppner TR; Hermann DM; Wang H; Dai Y
    Aging (Albany NY); 2019 Jan; 11(2):328-349. PubMed ID: 30659163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway.
    Hu L; Zang MD; Wang HX; Li JF; Su LP; Yan M; Li C; Yang QM; Liu BY; Zhu ZG
    Mol Oncol; 2016 Nov; 10(9):1473-1484. PubMed ID: 27590684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.
    Roda JM; Sumner LA; Evans R; Phillips GS; Marsh CB; Eubank TD
    J Immunol; 2011 Aug; 187(4):1970-6. PubMed ID: 21765015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1α activation.
    Park SY; Lee SW; Kim HY; Lee WS; Hong KW; Kim CD
    Eur J Immunol; 2015 Apr; 45(4):1216-27. PubMed ID: 25545169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
    Zhu H; Zhang S
    J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
    Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
    Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo.
    Li Y; Sui H; Jiang C; Li S; Han Y; Huang P; Du X; Du J; Bai Y
    Cell Physiol Biochem; 2018; 48(5):2035-2045. PubMed ID: 30099443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
    Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
    Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of NF-κB signaling pathway during HCG-induced VEGF expression in luteal cells.
    Zhang Z; Huang Y; Zhang J; Liu Z; Lin Q; Wang Z
    Cell Biol Int; 2019 Mar; 43(3):344-349. PubMed ID: 30597662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-κB suppresses HIF-1α response by competing for P300 binding.
    Mendonça DB; Mendonça G; Aragão FJ; Cooper LF
    Biochem Biophys Res Commun; 2011 Jan; 404(4):997-1003. PubMed ID: 21187066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.
    Yang KQ; Liu Y; Huang QH; Mo N; Zhang QY; Meng QG; Cheng JW
    BMC Cancer; 2017 Dec; 17(1):878. PubMed ID: 29268703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.